Effect of intravitral injection of tissue plasminogen activator on visual acuity and retinal macular thickness
Not Applicable
- Conditions
- Age related macular degeneration.Degeneration of macula and posterior pole
- Registration Number
- IRCT201511064166N6
- Lead Sponsor
- Tabriz University of Medical Sciences-Vice Chancellor for Research and Technology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 54
Inclusion Criteria
hemoragic CNV due to AMD; early onset of symptom in the last month; history of good visual acuity in affected eye
Exclusion criteria: history of vitroretinal surgery; uveitis with vitroretinal impairment; corneal disease for example keratoconous, dystrophy and degeneration; any medial hazeness for example vitrous hemorrhage, significant cataract ,...; pathologic myopia; diabetic retinopathy macular edema, retinal detachment, retinal vascular disorder; significant optic nerve injury
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Visual acuity. Timepoint: Before the intervention, one month and 6 months later. Method of measurement: Snellen chart.;Macular thickness. Timepoint: Prior to the study, one month and six months later. Method of measurement: Macular OCT.
- Secondary Outcome Measures
Name Time Method